New evidence shows how technology is actively supporting patients in managing their own health

December 14, 2016

A new Cochrane Review, summarizing data from 132 trials of automated telephone systems in preventing and managing long-term health conditions, concludes that they probably have the potential to play an important role in the delivery of health care. However, further research is needed to understand more about their acceptability and costs.

Automated telephone communication systems (ATCS) send voice messages to patients and may collect health information from people using their telephone's touch-tone keypad or voice-recognition software. Some ATCS also use SMS or email messaging and allow patients to ask for advice or support ('ATCS Plus'). Their use in healthcare is intended to support patients in actively managing their own health.

A team of Cochrane researchers assessed the effects of automated telephone communication systems compared with usual care for improving patient care in a variety of ways. These ranged from helping people take their medication as prescribed and reminding them about appointments, to using ACTS to increase the uptake of preventive healthcare measures such as immunization and cancer screening, and to improve the management of long-term conditions such as cancer, chronic pain, diabetes and mental illness.

The researchers included 132 trials, most of which were conducted in high income countries across Europe and North America. The studies compared ATCS against standard forms of usual care (i.e. no ATCS intervention).

Forty-one studies evaluated ATCS as a way of delivering preventative healthcare, by using reminders about attending appointments to receive immunizations or to get screened for different types of disease. Fives studies involving over 15,000 children and adolescents showed that providing reminders via ACTS probably increases immunization uptake compared with no reminder. When automated phone communication was used alongside other prompts such as mailed reminders the researchers found high quality evidence that this approach increases breast screening attendance by 20% in two studies in 462 women, and colorectal cancer screening by 30% based on three studies in 1013 people compared with usual care.

The Cochrane Review found low quality evidence that when compared with no reminders, simple automated systems may improve appointment attendance, which can play a key role in preventing disease.

Eighty-four studies evaluated ATCS in people with long-term conditions and whilst there was an indication that different types of ATCS helped to improve adherence with medicines, the effects on clinical outcomes were often mixed. The Review found low quality evidence in 1246 people with diabetes that blood glucose levels were slightly lower in treatment groups who received ATCS that had an interactive component, and moderate quality evidence that this approach helped people to monitor the health of their feet. ATCS with an interactive component probably reduces pain and depression in cancer patients when compared with ATCS alone. The effects on smoking cessation were uncertain, and there appeared to be little or no benefit in reducing blood pressure in people with hypertension.

The studies did not report adverse effects of the interventions and the researchers recommend that future research addresses issues of harms, feasibility and cost.

The Review's lead author, Josip Car, Director of Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, said these findings are promising and help to identify areas worth pursuing, "Our results show that ATCS may improve health-related outcomes in some long-term health conditions. These systems may also be a useful component in interventions for targeting adherence to medications, physical activity, and weight management and some outcomes in people with diabetes. However, the effects of ATCS are more uncertain in other areas such as HIV/ AIDS, hypertension, mental health, obstructive sleep apnoea or helping people to stop smoking."

He added, "Our Review shows that automated telephone communication systems may help change patients' health behaviours when compared with routine care. This is a positive step forward in eHealth for global health research. We need more information about the costs and harms to supplement the evidence that shows potential benefits of using these systems. Further research will help us to understand the patient experience with using these telecommunications systems, and how they could replace or supplement telephone contact between health professionals and patients in the future."
-end-
Editor's notes:

Full Citation: Posadzki P, Mastellos N, Ryan R, Gunn LH, Felix LM, Pappas Y, Gagnon MP, Julious SA, Xiang L, Oldenburg B, Car J.Automated telephone communication systems for preventive healthcare and management of long-term conditions.Cochrane Database of Systematic Reviews 2016, Issue 12. Art. No.: CD009921.DOI: 10.1002/14651858.CD009921.pub2.

Lead Author: Associate Professor Josip Car, MD PhD DIC MSc FFPH FRCP (Edin), Director of Centre for Population Health Sciences, Lee Kong Chian School of Medicine, Nanyang Technological University, 3 Fusionopolis Link, #03-08, Nexus@one-north, Singapore 138543, Singapore, and Director, Global eHealth Unit, Department of Primary Care and Public Health, Imperial College London, Charing Cross Campus, The Reynolds Building, St Dunstan's Road, London, W6 8RP.

E-mail: josip.car@ntu.edu.sg

For all media enquiries, please contact:
Jo Anthony
Senior Media and Communications Officer, Cochrane
M +44(0) 7582 726 634 E janthony@cochrane.org or pressoffice@cochrane.org

Dawn Peters
Sr. Specialist, External Communications and Media
+1 781-388-8408 E sciencenewsroom@wiley.com

About Cochrane

Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health. Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews. Cochrane is a not-for profit organisation with collaborators from more than 120 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognised as representing an international gold standard for high quality, trusted information.

Find out more at cochrane.org Follow us on twitter @cochranecollab

If you are a journalist or member of the press and wish to receive news alerts before their online publication or if you wish to arrange an interview with an author, please contact the Cochrane press office: pressoffice@cochrane.org

About Wiley

Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at http://www.wiley.com.

Wiley

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.